Institut Curie: all 134 studies
Page 1 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Adherence to Enteral NutritionRecruitingNCT07571564
- Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)RecruitingNCT07491380Not applicable
- Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapyNot yet recruitingNCT07357948Not applicable
- Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut CurieRecruitingNCT07357311
- Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast CancerRecruitingNCT07193394Phase 2
- Skin Reactions Related to Thoracic Implantable Chamber DressingsRecruitingNCT07158879
- Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.Not yet recruitingNCT07111117Phase 2
- Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)RecruitingNCT06659705Phase 2
- Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)RecruitingNCT06459791Not applicable
- Optimizing Bronchopulmonary Cancer ScreeningRecruitingNCT06439901Not applicable
- 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)RecruitingNCT06349512Not applicable
- Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)RecruitingNCT06225505Not applicable
- ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer PatientsRecruitingNCT06195709Phase 3
- Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyNot yet recruitingNCT06073548
- Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast CancerRecruitingNCT05955170Phase 2
- Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric OncologyRecruitingNCT05781295Not applicable
- Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)RecruitingNCT05558644Not applicable
- ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive CancersRecruitingNCT05441163Not applicable
- Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.RecruitingNCT05439005Phase 3
- Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTARecruitingNCT05354765Not applicable
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic TumoursRecruitingNCT05192980Not applicable
- Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4RecruitingNCT05088395Not applicable
- LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNGRecruitingNCT04790682Not applicable
- Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)RecruitingNCT04731610Not applicable
- Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual OutcomeRecruitingNCT04681417Phase 2/3
- Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)RecruitingNCT04424719Not applicable
- Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)RecruitingNCT03017573Not applicable
- COsegregation of VARiants in Panel of GenesRecruitingNCT01689584Not applicable
- Retrospective Analysis of the Efficacy of Morphine Gel to Treat Pain Associated With Perineal RadioDermatitisCompletedNCT07207889
- Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds (Tumoss)TerminatedNCT06581809Not applicable
- A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid TumorsTerminatedNCT06337630Phase 1
- Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT06175390Phase 2
- A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast CancerTerminatedNCT06162351Phase 2
- "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast CancerTerminatedNCT06067061Phase 1/2
- Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 QuestionnairesActive, not recruitingNCT05989191
- Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast CancerTerminatedNCT05932667Phase 2
- Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of TreatmentCompletedNCT05634395Not applicable
- Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2Status unknownNCT05554432
- Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic SignaturesActive, not recruitingNCT05475366Not applicable
- AsiDNA Children, Adolescents and Young AdultsTerminatedNCT05394558Phase 1/2
- Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange.CompletedNCT05293925
- Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)CompletedNCT05282901Phase 2
- Impact of Forearm Free Flap in Orbital Exenteration ReconstructionStatus unknownNCT05255315
- Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)CompletedNCT05141383Not applicable
- Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant ChemotherapyCompletedNCT05011721Not applicable
- Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE)Status unknownNCT04994730
- Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNGCompletedNCT04934865Not applicable
- Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in OncologyCompletedNCT04899505
- Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic TrialCompletedNCT04896099
- ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer SurgeryCompletedNCT04827030Phase 4
- Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.Active, not recruitingNCT04823377Not applicable
- Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local AnesthesiaCompletedNCT04804735Not applicable
- Study Evaluating Hot Flashes in Hormone Sensitive Breast CancerCompletedNCT04775043
- First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)CompletedNCT04733027Early Phase 1
- Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)CompletedNCT04728113Not applicable
- Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast CancerTerminatedNCT04720729Phase 2
- DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI)CompletedNCT04634097Not applicable
- The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)CompletedNCT04604873Not applicable
- Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV)CompletedNCT04541537Not applicable
- Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive OncologyCompletedNCT04478175Not applicable
- Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast CancerTerminatedNCT04469205Not applicable
- LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)Active, not recruitingNCT04446962Phase 1/2
- Study on Skin Toxicities Induced by Cancer TreatmentsCompletedNCT04402606Not applicable
- COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute PasteurCompletedNCT04369066Not applicable
- MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer SurgeryCompletedNCT04327063Phase 3
- Transcutaneous Breast Cancer Diagnosis by Canine OdorologyCompletedNCT04217109Not applicable
- Breast Cancer Risk After Diagnostic Gene SequencingCompletedNCT04145817Not applicable
- Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)CompletedNCT04118062Not applicable
- Study of the Activity of PD-1 Inhibitors in Metastatic Uveal MelanomaCompletedNCT03964298
- Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young AdultsCompletedNCT03964116Not applicable
- FErtility, PrEgnancy, contRaceptIon After Breast Cancer in FranceCompletedNCT03884413
- Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)CompletedNCT03739775Not applicable
- Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast CancerCompletedNCT03703557Not applicable
- Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian TumorCompletedNCT03690440
- Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)Active, not recruitingNCT03496402Not applicable
- Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL)CompletedNCT03298893Phase 1/2
- Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)CompletedNCT03109080Phase 1
- SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02)CompletedNCT03084757Not applicable
- MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)Active, not recruitingNCT03026998Not applicable
- First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)CompletedNCT03011528Phase 2
- Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)CompletedNCT02875652Not applicable
- Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)CompletedNCT02874040Not applicable
- Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)Active, not recruitingNCT02870907Phase 2
- Analysis of Circulating Tumor Markers in the Blood (ALCINA)CompletedNCT02866149Not applicable
- Conservative Treatments of RetinoblastomaActive, not recruitingNCT02866136Phase 2
- Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic ClassificationCompletedNCT02864563Not applicable
- FSH-R : Diagnostic Application for Localized Tumors in CancerologyTerminatedNCT02860481Not applicable
- Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.Status unknownNCT02857699
- Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care ConsultationCompletedNCT02854293
- Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal AdenocarcinomaCompletedNCT02849158Not applicable
- Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)CompletedNCT02849145Not applicable
- Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal CancerCompletedNCT02849106Not applicable
- Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal MelanomaCompletedNCT02843386Phase 3
- Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)CompletedNCT02842723Phase 2
- Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized TrialCompletedNCT02839473Phase 3
- Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), NEOELASTOCompletedNCT02834494Not applicable
- A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)CompletedNCT02831634Not applicable
- Optimizing the Care Pathways of Patients Treated for Operable Breast.CompletedNCT02813317
- Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT TracersCompletedNCT02802969Phase 2
- Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)CompletedNCT02608346Not applicable